September 12, 2024
 

CDC Updates 2024-2025 COVID-19 Vaccine Recommendations

CDC has updated its summary of recent changes for 2024-2025 COVID-19 vaccine recommendations. These clinical considerations provide healthcare professionals with information on:

  • Use of COVID-19 vaccines
  • Vaccine composition
  • Groups recommended for vaccination
  • Overview of vaccination schedules


Access the full guidelines here. CDC also updated their Use of COVID-19 Vaccines in the United States page with additional vaccine information for providers.
 

Study: Early Antiviral Treatment Lowers Flu Death Risk

A recent CDC study highlights the importance of starting antiviral treatment early in adults hospitalized with the flu. Analyzing data from over 26,000 patients across seven flu seasons, the research shows a significant reduction in the risk of death when treatment begins promptly.


These findings reinforce the CDC’s recommendation to initiate antiviral treatment as soon as possible for hospitalized patients with suspected or confirmed flu. Read more.
 

NFID Annual Respiratory Disease News Conference

Register for the NFID Annual News Conference on September 25, 2024, where CDC Director Dr. Mandy Cohen and other leading experts will present the final data from the 2023-2024 U.S. respiratory season. The conference will emphasize the importance of vaccination against flu, RSV, COVID-19, and pneumococcal disease.


For more details and registration, visit the 2024 NFID Annual News Conference website.

 
 

COVID-19 cases in nursing homes are 9.5 per 1,000 residents as of September 1, yet only 31% are up-to-date on vaccines. CDC recommends the 2024/2025 COVID-19 vaccine for people 6 months and older—visit our WAVE page for resources.
 

Chronic Conditions Corner

Recent research reveals that vaccines do more than prevent infectious diseases – they can also protect your heart. As healthcare providers, we want to highlight this important connection. Studies show that vaccinations against viral diseases like COVID-19, influenza, and shingles offer significant cardiovascular benefits. Here's why:


Viral infections can cause inflammation, potentially leading to heart attacks and strokes in at-risk individuals. COVID-19 is linked to an increased risk of heart problems. The risk of a heart attack may be up to six times higher in the week after a flu diagnosis.

Vaccines Every Heart Patient Should Consider:

  • Annual Influenza Vaccine
  • COVID-19 Vaccine
  • Pneumococcal Vaccines
  • Shingles Vaccine (for adults 50 and older)

The CDC recommends that people with heart disease or a history of stroke discuss these vaccinations with their healthcare team. While vaccines can have side effects, the benefits typically outweigh the risks for most patients.


Learn more about the benefits of vaccines for heart health at www.heart.org.


For guidelines, visit: cdc.gov/vaccines.
 

Shot of Knowledge: Vaccine Q&A

Are any of the available influenza vaccines recommended over others?


The recommendations vary by age group.

  • For people aged 6 months to 64 years:
  • CDC recommends any available age-appropriate influenza vaccine product.
  • For adults aged 65 years and older, three influenza vaccines are preferentially recommended:
  1. Fluzone High-Dose
  2. Flublok recombinant
  3. Fluad adjuvanted

Note: In June 2022, ACIP concluded that these three vaccines are potentially more effective than standard dose vaccines for this age group.

Should our practice consider revaccinating our high-risk and older patients a second time with the influenza vaccine during the year due to concerns with waning immunity?


No. CDC and ACIP do not recommend revaccination later in the season for people who have been fully vaccinated for the season, regardless of when they received the current season's vaccine.


For more vaccine FAQs, visit immunize.org. For updated immunization schedules, visit our WAVE page.
 

Learning & Professional Development

IP3 - Office Hours for Infection Preventionists

Join our IP3 group for engaging and insightful discussions with fellow infection preventionists! Share innovative ideas and explore new strategies to enhance infection prevention practices.


Hosted by Melanie Ronda, MSN, RN, and Mary Ellen Casey, MSN, RN, our meetings take place every Thursday at 11 am ET. Register.

Have You Visited IPRO Learn Yet?

Explore our diverse online course catalog and enhance your knowledge at your own pace - sign up today!


Need help? See our IPRO Learn Account Creation Instructions.
 
 
 

Stay informed about vaccine updates:


  • Visit our WAVE page to access up-to-date resources to support your efforts

Keep the learning going:


  • Visit our calendar to register for upcoming events
  • Access on-demand training with IPRO Learn!

For questions or technical assistance:
 
Visit Our Resource Library
Join Our Network
 
 
Facebook  Linkedin  X  Youtube
The IPRO QIN-QIO works to ensure high-quality, safe health care in New England, New York, New Jersey, Ohio, Delaware, Maryland, and the District of Columbia.
 
This material was prepared by the IPRO QIN-QIO, a Quality Innovation Network-Quality Improvement Organization, under contract with the Centers for Medicare & Medicaid Services (CMS), an agency of the U.S. Department of Health and Human Services (HHS). Views expressed in this document do not necessarily reflect the official views or policy of CMS or HHS, and any reference to a specific product or entity herein does not constitute endorsement of that product or entity by CMS or HHS. 12SOW-IPRO-QIN-T1-AA-21-435

IPRO QIN-QIO | 235 Promenade Street Suite 500, Box 18 | Providence, RI 02908 US

Unsubscribe | Update Profile | Our Privacy Policy | Constant Contact Data Notice

Constant Contact